NexImmune: Selling For Under Cash Value (NASDAQ:NEXI)
seekingalpha.com
finance
2022-05-31 21:58:19

Design Cells/iStock via Getty Images Science fiction films are not about science. They are about disaster, which is one of the oldest subjects of art."â€• Susan Sontag Today we take an in-depth look at a small developmental concern focused using T cells to develop treatments. Like so many small biotech stocks, the shares are deep in Busted IPO territory in what has been a brutal couple of quarters for the sector. Some insiders have recently made purchases, and there are some potential catalysts on the horizon as well.
